What's new

Annex - National provisions for SMEs applicable to the pharmaceutical sector

Annex - National provisions for SMEs applicable to the pharmaceutical sector

Feb 26, 2025 - 16:17
 0
Annex - National provisions for SMEs applicable to the pharmaceutical sector
Read More

Tags:

Previous Article

Fierce Biotech Fundraising Tracker '25: Eikon's eye-catching $350M series D; Bam...

Next Article

Certificates Processing System: Demo & Q&A session for industry stakeholders, On...

Related Posts

Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Date of authorisation: 10/02/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 11, 2025  0

PSUSA/00010774/202403

PSUSA/00010774/202403

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Trumenba, meningococcal group b vaccine (recombinant, adsorbed), Date of authorisation: 24/05/2017, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 25, 2025  0